Patent USRE34726E successfully refreshed from Google Patents.
USRE34726E
Expired / Lapsed
US
⏱️ 0.0 years remaining
Ferroelectric liquid crystal compositions containing chiral haloalkoxy tail units
Assignee: Micron Technology Inc
•
Filing: 1993-04-29
•
Granted: 1994-09-13
•
Expires: 2013-04-29
Abstract
Abstract The subject application discloses a chiral nonracemic composition of the general formula: R.sub.1 --Ar--O--CH.sub.2 --C*HX--C*HY--CH.sub.2 --O--R.sub.2 wherein R 1 is an achiral tail of two to sixteen carbons; Ar is an achiral FLC core of at least two rings; * denotes a chiral carbon; X and Y are halogens; and R 2 is one to ten carbon atoms. The --O--CH 2 --C*HX--C*HY--CH 2 --O-- segment comprises the chiral proximal segment of the chiral tail; the proximal segment is selected from the enantiomers 2R,3R-dihalo and 2S,3S-dihalo. R 2 is the distal segment of the chiral tail.
Inventors
- 👤 Michael Wand
- 👤 William N. Thurmes
- 👤 David Walba
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-10 02:31
CPC Classifications
C; C07; C07D; C07D239/00; C07D239/02; C07D239/24; C07D239/26; C07C; C07C69/00; C07C69/76; C07C69/84; C07C69/92; C09; C09K; C09K19/00; C09K19/04; C09K19/06; C09K19/08; C09K19/10; C09K19/12; C09K19/126; C09K19/20; C09K19/2007; C09K19/2021; C09K19/34; C09K19/3441; C09K19/345; C09K19/3458; C09K19/3463; C09K19/52; C09K19/58; C09K19/586; C09K19/588
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
174 words
A chiral nonracemic compound of the formula: R.sub.1 --AR--O--CH.sub.2 --C*HX--C*HY--CH.sub.2 --O--R.sub.2 wherein * denotes a chiral carbon, X and Y are halogens selected from the group of chlorine and fluorine, the .[.--O--CH 2 --C*HX--C--HY--CH 2 --O--.]. .Iadd.--O--CH 2 --C*HX--C*HY--CH 2 --O-- .Iaddend.segment comprises the chiral proximal segment of the chiral tails, said proximal segment being selected from the enantiomers 2R,3R-dihalo and 2S,3S-dihalo, R 1 is an achiral alkyl, alkyl sulfide, alkyl ether, alkenyl, alkenyl sulfide, alkenyl ether, alkoxy, alkoxy sulfide, or alkoxy ether group of two to sixteen carbons, Ar is an achiral FLC core selected from the group consisting of phenylbenzoates, phenylpyrimidines, biphenyls, phenylpyridines, biphenylbenzoates, diphenylpyrimidines, diphenylpyridines, terphenyls, phenyldiazenes, diphenyldiazenes, and diphenylthiadiazoles, and the chiral proximal segment and R 1 para-substituted with respect to each other on outer rings of said core, and R 2 is a distal segment of the chiral tail comprising one to ten carbon atoms and is selected from the group consisting of alkdehyde, alkyl acyl, alkyl, alkenyl, alkenyl acyl, alkyl halide, alkenyl halide, alkyl epoxide, and alkenyl epoxide.
Claim 2
Dependent Claim
174 words
A chiral nonracemic compound of the formula: R.sub.1 --AR--O--CH.sub.2 --C*HX--C*HY--CH.sub.2 --O--R.sub.2 wherein * denotes a chiral carbon, X and Y are halogens selected from the group of chlorine and fluorine, the .[.--O--CH 2 --C*HX--C--HY--CH 2 --O--.]. .Iadd.--O--CH 2 --C*HX--C*HY--CH 2 --O-- .Iaddend.segment comprises the chiral proximal segment of the chiral tails, said proximal segment being selected from the enantiomers 2R,3R-dihalo and 2S,3S-dihalo, R 1 is an achiral alkyl, alkyl sulfide, alkyl ether, alkenyl, alkenyl sulfide, alkenyl ether, alkoxy, alkoxy sulfide, or alkoxy ether group of two to sixteen carbons, Ar is an achiral FLC core selected from the group consisting of phenylbenzoates, phenylpyrimidines, biphenyls, phenylpyridines, biphenylbenzoates, diphenylpyrimidines, diphenylpyridines, terphenyls, phenyldiazenes, diphenyldiazenes, and diphenylthiadiazoles, and the chiral proximal segment and R 1 para-substituted with respect to each other on outer rings of said core, and R 2 is a distal segment of the chiral tail comprising one to ten carbon atoms and is selected from the group consisting of alkdehyde, alkyl acyl, alkyl, alkenyl, alkenyl acyl, alkyl halide, alkenyl halide, alkyl epoxide, and alkenyl epoxide.
Claim 3
Dependent Claim
13 words
The compound of claim 1, wherein R 1 comprises five to sixteen carbons.
Claim 4
Dependent Claim
11 words
The compounds of claim 4, wherein R 1 comprises eight carbons.
Claim 5
Dependent Claim
17 words
The compound of claim 1, wherein R 1 is selected from the group of straight-chain or branched.
Claim 6
Dependent Claim
11 words
The compound of claim 1, wherein R 2 comprises three carbons.
Claim 7
Dependent Claim
17 words
The compound of claim 1, wherein R 2 is selected from the group of straight-chain and branched.
Claim 8
Dependent Claim
12 words
The compound of claim 1, wherein R 2 comprises a chiral carbon.
Claim 9
Dependent Claim
16 words
The compound of claim 1, wherein R 2 is an alkyl halide consisting of two halogens.
Claim 10
Dependent Claim
13 words
The compound of claim 1, wherein said alkyl halides comprise fluorine or chlorine.
Claim 11
Dependent Claim
65 words
The compound of claim 1, wherein said composition is selected from the group consisting of .[.4'-[(2R,3R-difluoro-4-formyl)-butyloxy]phenyl-4-hexylpyrimidine.]. .Iadd.2-4'-(2R,3R-difluoro-4-formyloxybutyloxy)phenyl]-5-hexylpyrimidine .Iaddend.(X); .[.4'-[(2R,3R-difluoro-4-acetyl)butyloxy]phenyl-4-hexylpyrimidine.]. .Iadd.2-[4'-(2R,3R-difluoro-4-acetoxybutyloxy)phenyl]-5-hexylpyrimidine .Iaddend.(XI); .[.4'-[(2R,3R-difluoro-4-acetyl)butyloxy]phenyl-4-heptylpyrimidine.]. .Iadd.2-[4'-(2R,3R-difluoro-4-acetoxybutyloxy)phenyl]-5-heptylpyrimidine .Iaddend.(XII); .[.4'-[(2R,3R-difluoro-4-propanoate)butyloxy]phenyl-4-hexylpyrimidine.]. .Iadd.2-[4'-(2R,3R-difluoro-4-propanoatebutyloxy)phenyl]-5-hexylpyrimidine .Iaddend.(XIII); .[.4'-[(2R,3R-difluoro-4-butanoate)-butyloxy]phenyl-4-hexylpyrimidine.]. .Iadd.2-[4'-(2R,3R-difluoro-4-butanoatebutyloxy)phenyl]-5-hexylpyrimidine .Iaddend.(XIV); .[.4'-[(2R,3R-difluoro-4-pentanoate)butyloxy]phenyl-4-heptylpyrimidine.]. .Iadd.2-[4'-(2R,3R-difluoro-4-pentanoatebutyloxy)phenyl]-5-heptylpyrimidine .Iaddend.(XV); .[.4'-[2R,3R-difluoro-4-(4-pentanoate)-butyloxy]phenyl-4-hexylpyrimidine.]. .Iadd.2-{4'-[2R,3R-difluoro-4-(pent-4-enoate)butyloxy]phenyl}-5-hexylpyrimidine .Iaddend.(XVI); .[.4'-[2R,3R-difluoro-4-methoxy)butyloxy]-phenyl-4-heptylpyrimidine.]. .Iadd.2-[4'-(2R,3R-difluoro-4-methoxybutyloxy)phenyl]-5-heptylpyrimidine .Iaddend.(XVII); .[.4'-[(2R,3R-difluoro-4-butyloxy) butanoxy]phenyl-4-heptylpyrimidine.]. .Iadd.2-4'( 2R,3R-difluoro-4-butyloxybutyloxy)phenyl]-5-heptylpyrimidine .Iaddend.(XVIII); .[.4'-(2R,3R-difluoro-4-(4-pentenoxy)-butyloxy)phenyl-4-hexylpyrimidine.]. .Iadd.2-{4'-[2R,3R-difluoro-4-(pent-4-enoxy)butyloxy]phenyl}-5-hexylpyrimidine .Iaddend.(XIX); .[.4'-(2R,3R-difluoro-4-(1-methylheptyloxy)buty oxy)- phenyl-4-4-hexylpyrimidine.]. .Iadd.2-{4'-[2R,3R-difluoro-4-(R-1-methylheptyloxy)butyloxy]phenyl}-5-hexylpyrimidine .Iaddend.(XX); .[.4'-{[2R,3R-difluoro-4-(2R,3R-epoxy)hexyloxy]butyloxy}phenyl-4-hexylpy.]. .Iadd.2-{4'-[2R,3R-difluoro-4-(2R,3R-epoxyhexyloxy)butyloxy]phenyl}-5-hexylpyrimidine .Iaddend.(XXI); .[.4'-{[2R,3R-difluoro-4-(2S,3S-epoxy)hexyloxy]butyloxy}phenyl-4-hexylpyrimidine.]. .Iadd.2-{4'-[2R,3R-difluoro-4-(2S,3S-epoxyhexyloxy)butyloxy]phenyl}-5-hexylpyrimidine .Iaddend.(XXIII); .[.4'-[2R,3R-difluoro-4-(2S,3S-difluorohexyloxy)butyloxy]phenyl-4-hexylpyrimidine.]. .Iadd.2-{4'-[2R,3R-difluoro-4-(2S,3S-difluorohexyloxy)butyloxy]phenyl}-5-hexylpyrimidine .Iaddend.(XXIV); and .[.4'-[2R,3R-difluoro-4-(2R,3R-difluorohexyloxy)butyloxy]phenyl-4-hexylpyrimidine.]. .Iadd.2-{4'-[2R,3R-difluoro-4-(2R,3R-difluorohexyloxy)butyloxy]phenyl}-5-hexylpyrimidine .Iaddend.(XXII).
Claim 12
Dependent Claim
9 words
An FLC composition comprising the compound of claim 1.
References Cited (Backward Citations)
US4725688A
Cited
US4556727A
Cited
US4728458A
Cited
WO1986006373A1
Cited
JPS62111939A
Cited
US4798680A
Cited
EP0225236A1
Cited
EP0220747A2
Cited
JPS62258361A
Cited
WO1987005018A2
Cited
US4795587A
Cited
JPS63264573A
Cited
US4777280A
Cited
US4695650A
Cited
EP0263437A2
Cited
EP0267585A2
Cited
EP0269062A2
Cited
EP0278665A2
Cited
WO1989002425A1
Cited
US5051506A
Cited
US5167855A
Cited
US5180520A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-09-12 | 1998-03-14 | 1998-09-13 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-09-12 | 2002-03-14 | 2002-09-13 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-09-12 | 2006-03-14 | 2006-09-13 | $7700.00 | Window Closed / Lapsed |